Last reviewed · How we verify
Active smoked cannabis
At a glance
| Generic name | Active smoked cannabis |
|---|---|
| Also known as | marijuana, cannabis sativa, C. sativa L., C. sativa. Cannabis sativa L., Cannabis indica, C. indica |
| Sponsor | Bayliss J. Camp, PhD |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Cannabis Effects as a Function of Sex (PHASE1)
- Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery (PHASE1)
- Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes (PHASE1)
- Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment? (PHASE1)
- Behavioral Pharmacology of Cannabis and Nicotine (PHASE1)
- Cannabis Consumption and Driving Impairment Assessment on a Closed Course (PHASE2)
- Eye Tracking as a Biomarker of Cannabis Effects (PHASE2)
- Patient Doctor Lies (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Active smoked cannabis CI brief — competitive landscape report
- Active smoked cannabis updates RSS · CI watch RSS
- Bayliss J. Camp, PhD portfolio CI